UBC's Blog

UBC is committed to sharing ideas & insights with the pharmaceutical & biotech industry to address the full product lifecycle & support the development & commercialization of safe & effective products.


 What We Learned at DIA: Real-World Applications to Improving Healthcare
- July 03, 2017
During DIA’s Annual Meeting, June 18-22, in Chicago, the UBC team met hundreds of like-minded professionals, across dozens of disciplines, all focused on the goal of gaining and sharing knowledge to improve healthcare. We know that...
Post-marketing research can help show value of biopharmaceutical products
- June 15, 2017
Manufacturers of biopharmaceutical products and medical devices understand that the regulatory approval of their product will bring postmarketing challenges, requiring strategic and innovative solutions for continued surveillance of...
UBC has been recognized for excellence in clinical trials communications
- June 09, 2017
A leader in patient engagement across all aspects of drug development, access, and adherence, UBC has received seven awards for excellence in marketing and communications from two distinguished organizations. The Healthcare...
Don't miss our DIA preconference tutorial on REMS Assessment Reports
- June 01, 2017
Creating a REMS assessment report requires a high-functioning, coordinated team effort, often involving numerous departments and external vendors. UBC’s REMS experts have designed, implemented, and/or evaluated more than 100 RiskMAPS...
May is Lupus Awareness Month
Nicole Hebbert, VP, Patient Access & Engagement - May 25, 2017
The National Institutes of Health estimates more than 23 million Americans suffer from autoimmune disease, and that number is increasing every year.  Today, autoimmune diseases receive a significant amount of attention and new...